Clinical Trial Update: Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating adjuvant cisplatin plus gemcitabine versus capecitabine in triple-negative breast cancer patients who did not achieve pathologic compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Assiut University | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING